[PDF][PDF] Simultaneous SPECT studies of pre-and postsynaptic dopamine binding sites in baboons

SHJ Dresel, MP Kung, XF Huang, K Plössl… - Journal of Nuclear …, 1999 - Soc Nuclear Med
Department ofRadiology, University ofPennsylvania, Philadelphia, Pennsylvania
management. It is possible to achieve this by using 1231.. labeled compounds in two …

Imaging of striatal dopamine D2 receptors with a PET system for small laboratory animals in comparison with storage phosphor autoradiography: a validation study …

S Nikolaus, R Larisch, M Beu, H Vosberg… - Journal of Nuclear …, 2001 - Soc Nuclear Med
Several groups have developed high-resolution PET systems and shown the feasibility of in
vivo studies on small laboratory animals. In this investigation, one of these systems was …

[PDF][PDF] Graphical analysis and simplified quantification of striatal and extrastriatal dopamine D2 receptor binding with [123I] epidepride SPECT

M Ichise, M Fujita, JP Seibyl… - Journal of Nuclear …, 1999 - Soc Nuclear Med
Methods: Multilinear regression analysis (MLRA) and graphical analysis (GA) using plasma
parent (P) plus metabolite (M) activities as input and time activities of receptor-free (RF …

[PDF][PDF] In vivo SPECT imaging of CNS D-2 dopamine receptors: initial studies with iodine-123-IBZM in humans

HF Kung, A Alavi, W Chang, MP Kung… - Journal of Nuclear …, 1990 - Soc Nuclear Med
Subjectschosen for initial studies were male volunteers (a total of nine, age: 18— 50,
mean= 28) who had no history of prior neurologic or psychiatric disorders. Informed consent …

[PDF][PDF] Simplified quantification and reproducibility studies of dopamine D2-receptor binding with iodine-123-IBF SPECT in healthy subjects

M Ichise, JR Ballinger, D Vines, S Tsai… - Journal of Nuclear …, 1997 - Soc Nuclear Med
ÖPECT imaging of dopamine D2-receptors using I23l-labeled benzamide analogs such as
[I23l] iodobenzamide (IBZM) and [I23l] iodobenzofuran (IBF) is a potentially useful tool to …

[CITATION][C] SPECT imaging of dopamine receptors

M Ichise, JR Ballinger - Journal of Nuclear Medicine, 1996 - Soc Nuclear Med
FIGURE 3. Percent specific striatimi uptake for 123l-epidepridecompared with 123I-IBZM
(mean ±sd).* p< 0.05 compared with 123I-IBZM,** p< 0.01 compared with 123I-IBZM. the …

Dynamic SPECT in two healthy volunteers to determine the optimal time for in vivo D2 dopamine receptor imaging with123I-IBZM using the rotating gamma camera

N Verhoeff, T Brucke, I Podreka… - Nuclear medicine …, 1991 - journals.lww.com
Dynamic SPECT was performed in two healthy male volunteers with a single slice brain
dedicated camera (Strichman Medical Equipment 810, first study) and a rotating gamma …

Comparison of three high affinity SPECT radiotracers for the dopamine D2 receptor

MS Al-Tikriti, RM Baldwin, Y Zea-Ponce… - Nuclear medicine and …, 1994 - Elsevier
The regional brain distribution and pharmacological specificity of three high affinity tracers
for the dopamine (DA) D 2 receptor:[123 I] IBF,[123 I] epidepride, and [123 I] 2′-ISP were …

[PDF][PDF] Dosimetry of a D2/D3 dopamine receptor antagonist that can be used with PET or SPECT

PD Mozley, JB Stubbs, HJ Kim, W McElgin… - Journal of Nuclear …, 1995 - Soc Nuclear Med
The sequenceof measurementswas designedto acquirethe early emission images
immediately after the transmission scans without moving the subject so that the two sets of …

[PDF][PDF] Regional analysis of D2 dopamine receptors in Parkinson's disease using SPECT and iodine-123-iodobenzamide

SE Nadeau, MW Couch, CL Devane… - Journal of Nuclear …, 1995 - Soc Nuclear Med
PD, the previouslyobserved inverse correlationbetween levodopadosageand D2-
receptordensityappearsto be most prominentin the leastdopamine-deplatedregion …